Evidence map›Paper›PMID 41981067›Full record

ArticleScientific reports2026

A complex interplay of various intracellular motifs determines G protein binding and activation of muscarinic receptors.

Sina B Kirchhofer, Volker Jelinek, Katharina Klingelhöfer, Anna-Lena Krett, Moritz Bünemann

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sina B KirchhoferDepartment of Pharmacology and Clinical Pharmacy, Marburg University, Karl-von-Frisch-Str. 2, 35043, Marburg, Germany.
Volker JelinekDepartment of Pharmacology and Clinical Pharmacy, Marburg University, Karl-von-Frisch-Str. 2, 35043, Marburg, Germany.
Katharina KlingelhöferDepartment of Pharmacology and Clinical Pharmacy, Marburg University, Karl-von-Frisch-Str. 2, 35043, Marburg, Germany.
Anna-Lena KrettDepartment of Pharmacology and Clinical Pharmacy, Marburg University, Karl-von-Frisch-Str. 2, 35043, Marburg, Germany.
Moritz BünemannDepartment of Pharmacology and Clinical Pharmacy, Marburg University, Karl-von-Frisch-Str. 2, 35043, Marburg, Germany. moritz.buenemann@staff.uni-marburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G protein coupled receptors (GPCRs) mediate intracellular signaling by selectively activating heterotrimeric G proteins. While certain GPCRs exhibit a high specificity toward particular G protein subtypes, other GPCRs display promiscuous signaling by engaging interaction with multiple G protein families. Molecular determinants underlying the selectivity or promiscuity of the receptors remain incompletely understood. In the present study, we investigate various structural motifs within the intracellular domains of Muscarinic receptors to assess their role in both Gα subunit binding and activation. To this end, we generated chimeric receptors and applied both FRET- and BRET-based assays to monitor G protein binding and activation. Our study demonstrates that the determination of G protein coupling selectivity is not defined by single motifs or amino acids but rather by a complex interplay of various intracellular motifs affecting binding or/and subsequent activation. These results provide new insights into the structural basis of GPCR-G protein specificity.

Indexed as

GTP-Binding ProteinsReceptors, MuscarinicAmino Acid MotifsAmino Acid SequenceAnimalsFluorescence Resonance Energy TransferHEK293 CellsHumansProtein BindingSignal TransductionGTP-Binding ProteinsReceptors, Muscarinic

Identifiers

PMID41981067
PMCPMC13083859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.